{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"Acute Graft-Versus-Host Disease is a severe short-term complication created by infusion of donor cells into a foreign host.","groups":[{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 IV over 30 minutes DLI Cell Dose 1.0 x 10\\^8 CD3+ T-cells/kg","id":"OG000","title":"DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg"},{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 DLI Cell Dose 0.5 x 10\\^8 CD3+ T-cells/kg","id":"OG001","title":"DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Number of Patients With Acute Graft-Versus-Host Disease","type":"SECONDARY","unitOfMeasure":"Participants"}